TVTXTravere Therapeutics, Inc.May 4, 2026Q1 2026
Read transcript →Travere Therapeutics, Inc. (TVTX) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$56.60
+3.00%
Mkt Cap $5.17B
TVTXTravere Therapeutics, Inc.May 4, 2026TVTXTravere Therapeutics, Inc.Feb 19, 2026Q4 2025
Read transcript →TVTXTravere Therapeutics, Inc.Oct 30, 2025Q3 2025
Read transcript →TVTXTravere Therapeutics, Inc.Aug 6, 2025Q2 2025
Read transcript →TVTXTravere Therapeutics, Inc.May 1, 2025Q1 2025
Read transcript →TVTXTravere Therapeutics, Inc.Feb 21, 2025Q4 2024
Read transcript →TVTXTravere Therapeutics, Inc.Oct 31, 2024Q3 2024
Read transcript →TVTXTravere Therapeutics, Inc.Aug 3, 2024Q2 2024
Read transcript →TVTXTravere Therapeutics, Inc.May 6, 2024Q1 2024
Read transcript →TVTXTravere Therapeutics, Inc.Feb 16, 2024Q4 2023
Read transcript →TVTXTravere Therapeutics, Inc.Nov 7, 2023Q3 2023
Read transcript →TVTXTravere Therapeutics, Inc.Aug 4, 2023Q2 2023
Read transcript →TVTXTravere Therapeutics, Inc.May 7, 2023Q1 2023
Read transcript →TVTXTravere Therapeutics, Inc.Feb 23, 2023Q4 2022
Read transcript →TVTXTravere Therapeutics, Inc.Oct 27, 2022Q3 2022
Read transcript →TVTXTravere Therapeutics, Inc.Aug 7, 2022Q2 2022
Read transcript →TVTXTravere Therapeutics, Inc.May 8, 2022Q1 2022
Read transcript →TVTXTravere Therapeutics, Inc.Feb 24, 2022Q4 2021
Read transcript →TVTXTravere Therapeutics, Inc.Oct 28, 2021Q3 2021
Read transcript →TVTXTravere Therapeutics, Inc.Jul 31, 2021Q2 2021
Read transcript →TVTXTravere Therapeutics, Inc.May 9, 2021Q1 2021
Read transcript →TVTXTravere Therapeutics, Inc.Mar 1, 2021Q4 2020
Read transcript →TVTXTravere Therapeutics, Inc.Nov 8, 2020Q3 2020
Read transcript →TVTXTravere Therapeutics, Inc.Aug 2, 2020Q2 2020
Read transcript →TVTXTravere Therapeutics, Inc.May 11, 2020Q1 2020
Read transcript →TVTXTravere Therapeutics, Inc.Feb 24, 2020Q4 2019
Read transcript →TVTXTravere Therapeutics, Inc.Oct 30, 2019Q3 2019
Read transcript →TVTXTravere Therapeutics, Inc.Aug 6, 2019Q2 2019
Read transcript →TVTXTravere Therapeutics, Inc.May 7, 2019Q1 2019
Read transcript →TVTXTravere Therapeutics, Inc.Feb 26, 2019Q4 2018
Read transcript →TVTXTravere Therapeutics, Inc.Nov 1, 2018Q3 2018
Read transcript →TVTXTravere Therapeutics, Inc.Jul 26, 2018Q2 2018
Read transcript →TVTXTravere Therapeutics, Inc.May 1, 2018Q1 2018
Read transcript →TVTXTravere Therapeutics, Inc.Feb 27, 2018Q4 2017
Read transcript →TVTXTravere Therapeutics, Inc.Nov 11, 2017Q3 2017
Read transcript →TVTXTravere Therapeutics, Inc.Aug 11, 2017Q2 2017
Read transcript →TVTXTravere Therapeutics, Inc.May 4, 2017Q1 2017
Read transcript →TVTXTravere Therapeutics, Inc.Mar 1, 2017Q4 2016
Read transcript →TVTXTravere Therapeutics, Inc.Nov 3, 2016Q3 2016
Read transcript →TVTXTravere Therapeutics, Inc.Aug 4, 2016Q2 2016
Read transcript →TVTXTravere Therapeutics, Inc.May 3, 2016Q1 2016
Read transcript →TVTXTravere Therapeutics, Inc.Feb 25, 2016Q4 2015
Read transcript →TVTXTravere Therapeutics, Inc.Nov 3, 2015Q3 2015
Read transcript →TVTXTravere Therapeutics, Inc.Aug 4, 2015Q2 2015
Read transcript →TVTXTravere Therapeutics, Inc.May 12, 2015Q1 2015
Read transcript →TVTXTravere Therapeutics, Inc.Mar 5, 2015Q4 2014
Read transcript →TVTXTravere Therapeutics, Inc.Nov 13, 2014Q3 2014
Read transcript →TVTXTravere Therapeutics, Inc.Aug 12, 2014Q2 2014
Read transcript →TVTXTravere Therapeutics, Inc.Mar 27, 2014Q4 2013
Read transcript →TVTXTravere Therapeutics, Inc.Nov 18, 2013Q3 2013
Read transcript →